Stock Market Update
20-Jun-24 14:30 ET
Jabil slips on industry commentary, Gilead higher in S&P 500 after favorable HIV trial data
Dow +366.39
at 39201.25,
Nasdaq -110.65
at 17751.58,
S&P -4.97
at 5482.06
[BRIEFING.COM] The S&P 500 (-0.09%) is in second place, hovering just off afternoon highs in recent trading.
Elsewhere, S&P 500 constituents Jabil (JBL 112.90, -13.33, -10.56%), Enphase Energy (ENPH 109.62, -9.39, -7.89%), and Chipotle Mexican Grill (CMG 3219.84, -207.77, -6.06%) dot the bottom of the average. JBL is lower despite upside results/guidance as cautious comments related to the automotive and healthcare industries are weighing on shares, while ENPH dips after peer SMA Solar Tech AG cut its earnings and sales guidance for FY24.
Meanwhile, Gilead Sciences (GILD 68.04, +4.89, +7.74%) is atop the standings, propped up by news that its Phase 3 PURPOSE 1 trial for twice-yearly injectable HIV-1 capsid inhibitor, lenacapavir, demonstrated 100% efficacy for HIV prevention in cisgender women.
